Skip to content

Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation

The IntubAID Study - Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06139809
Acronym
IntubAID
Enrollment
50
Registered
2023-11-18
Start date
2024-03-31
Completion date
2025-10-05
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Newborn, Diseases, Intubation Complication

Keywords

Intubation, Non-invasive ventilation, Non-invasive positive pressure ventilation, Continuous positive airway pressure, Mechanical ventilation, Physiological stability

Brief summary

The goal of this study is to perform a quality control assessment of our local intubation protocol in any newborn infant requiring endotracheal intubation in the delivery room or neonatal intensive care unit at the Department of Neonatology of the University Hospital Zurich. The primary aims are: * Successful nasal intubation at the first attempt without physiological instability. * Comparison of infants with successful intubation at the first attempt without physiological instability to the infants in the SHINE-Trial in Australia. Participants will be intubated according to our standard intubation procedure using non-invasive ventilation (NIV) delivered through a nasopharyngeal tube.

Interventions

PROCEDUREIntubation

Intubation will take place according to our local standard protocol for nasal intubation using NIPPV delivered through a nasopharyngeal tube. The intubation will be video-recorded to provide a clear view of the procedure and the pulse oximeter displaying the SpO2 and HR.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

prospective single-center study

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Any neonate at the Department of Neonatology of the University Hospital Zurich undergoing endotracheal intubation in the delivery room or neonatal intensive care unit.

Exclusion criteria

* Requirement for immediate endotracheal intubation as determined by the treating clinician, without time for potential application of NIPPV, e.g. active cardiopulmonary resuscitation. * Contraindication to NIPPV use (e.g. congenital diaphragmatic hernia, abdominal wall defects). * Oral intubation planned. * Denial of parental consent and/or inability of the parents to understand the study procedures due to cognitive or linguistic reasons. * Withdrawal at the discretion of the intubating clinician if he / she feels the study is interfering with a safe and optimal treatment of the patient.

Design outcomes

Primary

MeasureTime frameDescription
Successful nasal intubation at the first intubation attempt without physiological instabilityfirst intubation attemptNumber of successful intubations at the first intubation attempt. Physiological instability is defined as the absolute decrease in SpO2 of \>20% from baseline and/or bradycardia with a heart rate of \<100 bpm for any duration during the first intubation attempt. Baseline is defined as the time immediately before removal of face mask or prong for placement of the nasopharyngeal tube. The intubation starts and ends with the insertion and removal of the laryngoscope blade beyond the infant's lip.

Secondary

MeasureTime frameDescription
Incidence of desaturationbaseline to begin of first intubation attemptNumber of desaturations (SpO2 \<80 %) between baseline and the begin of the first intubation attempt
Peripheral oxygen saturationbaseline to begin of first intubation attemptMean oxygen saturation over time between baseline and the begin of the first intubation attempt, SpO2 \[%\]
Heart ratebaseline to begin of first intubation attemptMean heart rate over time between baseline and the begin of the first intubation attempt, HR \[bpm\]
Time to desaturation during first intubation attemptfirst intubation attemptTime \[sec\] between time zero and desaturation (SpO2 \<80%) during the first intubation attempt. Time zero is defined as the time the laryngoscope is inserted past the infant's lips for the first intubation attempt.
Duration of desaturation during first intubation attemptfirst intubation attemptTime of SpO2 spent below 80% during the first intubation attempt
Time to bradycardia during first intubation attemptfirst intubation attemptTime \[sec\] between time zero and bradycardia (HR \<100 bpm) during the first intubation attempt.
Duration of bradycardia during first intubation attemptfirst intubation attemptTime of HR spent below 100 bpm during the first intubation attempt
Incidence of bradycardiabaseline to begin of first intubation attemptNumber of bradycardia (HR \<100 bpm) between baseline and the begin of the first intubation attempt
Number of intubation attemptsoverall intubation procedureTotal number of intubation attempts to successful intubation, \[n\]
Number of disconnections from ventilator circuitoverall intubation procedureTotal number of disconnections from ventilator circuit between baseline and end of intubation attempt(s), \[n\]
Incidence of cardiac compressionsWithin one hour of first intubation attemptIncidence of cardiac compressions within one hour after first intubation attempt, \[n\]
Incidence of epinephrine administrationWithin one hour of first intubation attemptIncidence of epinephrine administration within one hour after first intubation attempt, \[n\]
Incidence of pneumothorax requiring drainageWithin 24 hours of first intubation attemptIncidence of pneumothorax requiring drainage within 24 hours after first intubation attempt, \[n\]
Incidence of deathWithin 24 hours of first intubation attemptIncidence of death within 24 hours after first intubation attempt, \[n\]
Duration of intubation attempt(s)overall intubation procedureTime from baseline to successful intubation including all intubation attempts, \[sec\]

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026